Last update:
Medications news
Medications
Two powerful drugs now adding to US overdose crisis
Emerging reports show that two little-known drugs are making lethal new contributions to America's drug overdose crisis.
7 hours ago
1
23
Medications
Newer rheumatoid arthritis drug might raise heart, cancer risks
(HealthDay)—Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms.
13 hours ago
0
13
New drug screening method answers why Alzheimer's drugs fail, suggests new targets
By analyzing disease mechanisms in human neurons, researchers led by the University of California San Diego developed a new method to screen drugs for treating Alzheimer's disease. Their work sheds light on why Alzheimer's ...
13 hours ago
0
7
Scientists find link between antibiotics and colon cancer
Scientists from the University of Aberdeen, NHS Grampian and Queen's University Belfast have found that antibiotic use may increase the risk of developing colon cancer, potentially more so among younger people.
16 hours ago
0
112
New data on drug metabolism and distribution in the eye
Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested ...
16 hours ago
0
2
Macromolecular gel with therapeutic payload could be silver bullet for osteoarthritis
Osteoarthritis affects over 32 million Americans, levies a huge cost on society, and vastly increases one's chances of developing heart disease.
Jan 26, 2022
0
44
Active ingredient in cannabis protects aging brain cells
Decades of research on medical cannabis has focused on the compounds THC and CBD in clinical applications. But less is known about the therapeutic properties of cannabinol (CBN). Now, a new study by Salk scientists shows ...
Jan 26, 2022
0
180
Current anti-COVID pills work well against omicron, but antibody drugs are less effective
The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study.
Jan 26, 2022
0
53
Cancer drug shows promise in treating infants with rare disease that causes tissue overgrowth
PIK3CA-related overgrowth spectrum (PROS) is a group of rare, incurable disorders caused by mutations in the PIK3CA gene that result in the malformation and overgrowth of various parts of the body. A new report to be published ...
Jan 26, 2022
0
5
Study profiles side-effects linked to common immunosuppressant methotrexate
New research led by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) scientists has profiled the side effects of methotrexate—a common drug used to treat arthritis and other autoimmune diseases.
Jan 26, 2022
0
5
Compound from violets may help fight glioblastoma
A circular peptide derived from violets could lead to new approaches in treating glioblastoma, a highly aggressive form of brain cancer.
Jan 26, 2022
0
5
Casirivimab + imdevimab prevents progression to symptomatic COVID-19
(HealthDay)—For asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR)-positive individuals living with an infected household contact, treatment with the subcutaneous casirivimab ...
Jan 26, 2022
0
4
Psoriasis treatments can be life-changing
If you suffer from psoriasis, vibrant, clear skin is no longer out of reach. According to Rush dermatologists, new innovative treatments can help you put your best face forward.
Jan 26, 2022
0
2
Study shows decision-making tools proved ineffective in reducing prescription rates for antibiotics
Antibiotics are one of the great advances in modern medicine, but their over-prescription has led to resistant bacteria that are becoming more difficult to treat. The problem is particularly concerning in Australia, which ...
Jan 26, 2022
0
6
Skyrizi approved for psoriatic arthritis
(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.
Jan 26, 2022
0
1
Allopurinol not tied to higher mortality for patients with gout and chronic kidney disease
(HealthDay)—For patients with gout and chronic kidney disease (CKD), no associations with increased mortality were seen for allopurinol initiation, achieving target serum urate (SU) levels, or allopurinol dose escalation, ...
Jan 25, 2022
0
6
FDA limits use of two COVID antibody treatments
The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.
Jan 25, 2022
0
46
An effectiveness study to guide the treatment of depression in adolescents
A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that, combinatorial pharmacogenetics-guided treatment did not demonstrate improved outcomes for adolescents ...
Jan 25, 2022
0
2
Researchers discover way to disarm potentially deadly Listeria bacteria
University of Queensland researchers have unlocked a way of fighting Listeria infections, which can cause severe illness in pregnant women and people with compromised immune systems.
Jan 24, 2022
0
59
Can CBD help curb COVID? Maybe, but more study is needed
Cannabidiol, a compound derived from marijuana, appears to show promise in blocking replication of the COVID-19 virus and preventing its spread, lab and animal studies show.
Jan 24, 2022
0
27
